{
    "Orphapacket": {
        "ORPHApacketId": "100057",
        "creationDate": "2021-08-17 17:32:38",
        "version": "1.3.7 / 4.1.7 [2020-12-03] (orientdb version)",
        "copyright": "Orphanet (c) 2021",
        "ORPHAcode": "100057",
        "Label": "Renin-angiotensin-aldosterone system-blocker-induced angioedema",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_100057",
        "DisorderType": {
            "value": "Disease",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377788"
        },
        "Synonyms": [
            {
                "Synonym": "ACE inhibitor-related acquired angioedema"
            },
            {
                "Synonym": "ACEI-related acquired angioedema"
            },
            {
                "Synonym": "Acquired angioedema with normal C1 inhibitor"
            },
            {
                "Synonym": "Acquired angioedema with normal C1INH"
            },
            {
                "Synonym": "RAAS-blocker-induced angioedema"
            },
            {
                "Synonym": "RAAS-blocker-induced angioneurotic edema"
            },
            {
                "Synonym": "RAE"
            },
            {
                "Synonym": "Renin-angiotensin-aldosterone system-blocker-induced angioneurotic edema"
            }
        ],
        "ExternalReferences": [
            {
                "Source": "OMIM",
                "Reference": "300909",
                "DisorderMappingRelation": "BTNT (ORPHA code's Broader Term maps to a Narrower Term)"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "Renin-angiotensin-aldosterone system (RAAS)-blocker induced angioedema (RAE) is a type of acquired angioedema (AAE see this term) characterized by acute edema in subcutaneous tissues viscera and/or the upper airway."
        },
        "Genes": [
            {
                "Gene": {
                    "Symbol": "XPNPEP2",
                    "Name": "X-prolyl aminopeptidase 2",
                    "ExternalReferences": []
                }
            }
        ],
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "91385",
                        "Label": "Acquired angioedema"
                    }
                ]
            },
            {
                "Parent": [
                    {
                        "ORPHAcode": "231957",
                        "Label": "Disease associated with a genetic susceptibility or tested for a biomarker"
                    }
                ]
            }
        ],
        "Prevalences": {
            "Prevalence": [
                {
                    "Source": "ORPHANET",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Class only",
                    "PrevalenceClass": "Unknown",
                    "ValMoy": "0.0",
                    "PrevalenceGeographic": "Worldwide"
                }
            ]
        },
        "AverageAgeOfOnsets": {
            "AverageAgeOfOnset": [
                {
                    "value": "Adult"
                }
            ]
        },
        "TypeOfInheritances": [
            {
                "TypeOfInheritance": {
                    "value": "Multigenic/multifactorial"
                }
            },
            {
                "TypeOfInheritance": {
                    "value": "Not applicable"
                }
            }
        ]
    }
}